Vbi Vaccines Stock Performance
| VBIV Stock | USD 0.60 0.03 4.76% |
On a scale of 0 to 100, VBI Vaccines holds a performance score of 2. The firm has a beta of 0.34, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, VBI Vaccines' returns are expected to increase less than the market. However, during the bear market, the loss of holding VBI Vaccines is expected to be smaller as well. Please check VBI Vaccines' maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether VBI Vaccines' existing price patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in VBI Vaccines are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, VBI Vaccines showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:30 | Dividend Date 2012-12-28 | Last Split Date 2023-04-12 |
1 | Strategic Licensing Agreements Brii Bios Expansion into Chronic Disease Treatments with VBI Vaccines | 02/14/2024 |
2 | VBI Vaccines Inc to Discuss on FDA Approval of PreHevbrio for t | 03/05/2024 |
3 | VBI Vaccines expands collaboration with Canadian government | 04/02/2024 |
4 | VBI-1901 shows promise in glioblastoma study | 04/03/2024 |
5 | VBI Vaccines secures 2 million in direct offering | 04/09/2024 |
6 | VBI Vaccines Announces Closing of 2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 04/11/2024 |
7 | VBI Vaccines Reports Full Year 2023 Financial Results | 04/16/2024 |
8 | Individual investors account for 55 percent of VBI Vaccines Inc.s ownership, while private equity firms ... - Yahoo Movies UK | 04/17/2024 |
| Begin Period Cash Flow | 62.6 M |
VBI |
VBI Vaccines Relative Risk vs. Return Landscape
If you would invest 61.00 in VBI Vaccines on January 24, 2024 and sell it today you would lose (1.00) from holding VBI Vaccines or give up 1.64% of portfolio value over 90 days. VBI Vaccines is currently generating 0.2092% in daily expected returns and assumes 6.8483% risk (volatility on return distribution) over the 90 days horizon. In different words, 60% of stocks are less volatile than VBI, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
VBI Vaccines Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VBI Vaccines' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as VBI Vaccines, and traders can use it to determine the average amount a VBI Vaccines' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0305
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VBIV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.85 actual daily | 60 60% of assets are less volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average VBI Vaccines is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VBI Vaccines by adding it to a well-diversified portfolio.
VBI Vaccines Fundamentals Growth
VBI Stock prices reflect investors' perceptions of the future prospects and financial health of VBI Vaccines, and VBI Vaccines fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VBI Stock performance.
| Return On Equity | -2.59 | ||||
| Return On Asset | -0.29 | ||||
| Operating Margin | (14.49) % | ||||
| Current Valuation | 46.5 M | ||||
| Shares Outstanding | 28.43 M | ||||
| Price To Earning | (3.79) X | ||||
| Price To Book | 0.82 X | ||||
| Price To Sales | 2.02 X | ||||
| Revenue | 8.68 M | ||||
| Gross Profit | (10.19 M) | ||||
| EBITDA | (53.32 M) | ||||
| Net Income | (92.84 M) | ||||
| Cash And Equivalents | 82.41 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 53.04 M | ||||
| Debt To Equity | 0.32 % | ||||
| Current Ratio | 2.29 X | ||||
| Book Value Per Share | 0.32 X | ||||
| Cash Flow From Operations | (60.88 M) | ||||
| Earnings Per Share | (6.03) X | ||||
| Market Capitalization | 17.14 M | ||||
| Total Asset | 86.95 M | ||||
| Retained Earnings | (582.45 M) | ||||
| Working Capital | (39.51 M) | ||||
| Current Asset | 7.89 M | ||||
| Current Liabilities | 3.03 M | ||||
About VBI Vaccines Performance
To evaluate VBI Vaccines Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when VBI Vaccines generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare VBI Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand VBI Vaccines market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents VBI's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 213.98 | 224.68 | |
| Return On Tangible Assets | (1.88) | (1.79) | |
| Return On Capital Employed | (4.93) | (4.69) | |
| Return On Assets | (1.07) | (1.12) | |
| Return On Equity | (12.33) | (11.72) |
Things to note about VBI Vaccines performance evaluation
Checking the ongoing alerts about VBI Vaccines for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for VBI Vaccines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| VBI Vaccines had very high historical volatility over the last 90 days | |
| VBI Vaccines has some characteristics of a very speculative penny stock | |
| VBI Vaccines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.68 M. Net Loss for the year was (92.84 M) with loss before overhead, payroll, taxes, and interest of (10.19 M). | |
| VBI Vaccines currently holds about 82.41 M in cash with (60.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
| VBI Vaccines has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Individual investors account for 55 percent of VBI Vaccines Inc.s ownership, while private equity firms ... - Yahoo Movies UK |
- Analyzing VBI Vaccines' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether VBI Vaccines' stock is overvalued or undervalued compared to its peers.
- Examining VBI Vaccines' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating VBI Vaccines' management team can have a significant impact on its success or failure. Reviewing the track record and experience of VBI Vaccines' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of VBI Vaccines' stock. These opinions can provide insight into VBI Vaccines' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.